Search research articles
Contact Us
Filters
Showing results (171-180 of 715) with videos related to
Page
of 72
Sort By:
Thrombosis Research
|
November 15, 1981
On the fibrinolytic and thrombolytic properties of active-site p-anisoylated streptokinase-plasminogen complex (BRL 26921)
O Matsuo, D Collen, M Verstraete
European Journal of Biochemistry
|
June 1, 1978
On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin
B Wiman, L Boman, D Collen
Biochimica Et Biophysica Acta
|
May 27, 1977
On the origin of the Aalpha chain heterogeneity of human fibrinogen
N Semeraro, D Collen, M Verstraete
Thrombosis and Haemostasis
|
October 1, 1981
Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture
K Bykowska, D C Rijken, D Collen
Current Gene Therapy
|
July 12, 2002
Viral vector-mediated gene therapy for hemophilia
T VandenDriessche, D Collen, M K Chuah
Thrombosis and Haemostasis
|
December 27, 1982
Partial primary structure of human alpha 2-antiplasmin-homology with other plasma protease inhibitors
H R Lijnen, B Wiman, D Collen
Thrombosis Research
|
May 15, 1981
Histidine-rich glycoprotein in a normal and a clinical population
H R Lijnen, G Jacobs, D Collen
Biochimica Et Biophysica Acta
|
July 25, 1979
On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen
B Wiman, H R Lijnen, D Collen
Stroke
|
September 26, 1997
Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke model
S Vanderschueren, I Van Vlaenderen, D Collen
Blood
|
January 1, 1988
Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbits
D Collen, J M Stassen, G Larsen
Page
of 72
Search research articles
Search
Showing results (171-180 of 715) with videos related to
Sort By:
Page
of 72
Thrombosis Research
|
November 15, 1981
On the fibrinolytic and thrombolytic properties of active-site p-anisoylated streptokinase-plasminogen complex (BRL 26921)
O Matsuo, D Collen, M Verstraete
European Journal of Biochemistry
|
June 1, 1978
On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin
B Wiman, L Boman, D Collen
Biochimica Et Biophysica Acta
|
May 27, 1977
On the origin of the Aalpha chain heterogeneity of human fibrinogen
N Semeraro, D Collen, M Verstraete
Thrombosis and Haemostasis
|
October 1, 1981
Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture
K Bykowska, D C Rijken, D Collen
Current Gene Therapy
|
July 12, 2002
Viral vector-mediated gene therapy for hemophilia
T VandenDriessche, D Collen, M K Chuah
Thrombosis and Haemostasis
|
December 27, 1982
Partial primary structure of human alpha 2-antiplasmin-homology with other plasma protease inhibitors
H R Lijnen, B Wiman, D Collen
Thrombosis Research
|
May 15, 1981
Histidine-rich glycoprotein in a normal and a clinical population
H R Lijnen, G Jacobs, D Collen
Biochimica Et Biophysica Acta
|
July 25, 1979
On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen
B Wiman, H R Lijnen, D Collen
Stroke
|
September 26, 1997
Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke model
S Vanderschueren, I Van Vlaenderen, D Collen
Blood
|
January 1, 1988
Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbits
D Collen, J M Stassen, G Larsen
Page
of 72